Paper17631908
Reducing the risk of ICH enlargement.
Wartenberg KE and 1 other. J Neurol Sci, 2007. Cited by 21 papers, by iCite.
Cite this record
ConductScience Library. Reducing the risk of ICH enlargement. Papers, record 17631908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17631908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cerebral Hemorrhage | Major topic |
| Hemostatics | Major topic |
| Factor VIIa | |
| Glasgow Coma Scale | |
| Hematoma | |
| Humans | |
| Risk Factors |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36942509 | Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage. | CNS Neurosci Ther | 2023 | https://conductscience.org/library/papers/36942509 | PubMed |
| 35258849 | Interleukin-13 Affects the Recovery Processes in a Mouse Model of Hemorrhagic Stroke with Bilateral Tibial Fracture. | Mol Neurobiol | 2022 | https://conductscience.org/library/papers/35258849 | PubMed |
| 33986719 | Glibenclamide Advantage in Treating Edema After Intracerebral Hemorrhage (GATE-ICH): Study Protocol for a Multicenter Randomized, Controlled, Assessor-Blinded Trial. | Front Neurol | 2021 | https://conductscience.org/library/papers/33986719 | PubMed |
| 26980009 | Blocking B7-1/CD28 Pathway Diminished Long-Range Brain Damage by Regulating the Immune and Inflammatory Responses in a Mouse Model of Intracerebral Hemorrhage. | Neurochem Res | 2016 | https://conductscience.org/library/papers/26980009 | PubMed |
| 26552593 | MicroRNA367 negatively regulates the inflammatory response of microglia by targeting IRAK4 in intracerebral hemorrhage. | J Neuroinflammation | 2015 | https://conductscience.org/library/papers/26552593 | PubMed |
| 26365973 | Aggressive Blood Pressure Lowing Therapy in Patients with Acute Intracerebral Hemorrhage is Safe: A Systematic Review and Meta-analysis. | Chin Med J (Engl) | 2015 | https://conductscience.org/library/papers/26365973 | PubMed |
| 25328643 | Which emphasizing factors are most predictive of hematoma expansion in spot sign positive intracerebral hemorrhage? | J Korean Neurosurg Soc | 2014 | https://conductscience.org/library/papers/25328643 | PubMed |
| 24323867 | Depletion of GR-1-Positive Cells Is Associated with Reduced Neutrophil Inflammation and Astrocyte Reactivity after Experimental Intracerebral Hemorrhage. | Transl Stroke Res | 2012 | https://conductscience.org/library/papers/24323867 | PubMed |
| 24323621 | Sonothrombolysis: an emerging modality for the treatment of acute ischemic and hemorrhagic stroke. | Transl Stroke Res | 2011 | https://conductscience.org/library/papers/24323621 | PubMed |
| 23920016 | Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography. | Stroke | 2013 | https://conductscience.org/library/papers/23920016 | PubMed |
| 21286475 | Role of 'Spot Sign' on CT Angiography to Predict Hematoma Expansion in Spontaneous Intracerebral Hemorrhage. | J Korean Neurosurg Soc | 2010 | https://conductscience.org/library/papers/21286475 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17631908
GET https://conductscience.org/api/papers/v1/17631908/authors